Literature DB >> 16050486

Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.

Eveline Turatti1, Adriana da Costa Neves, Marina Helena Cury Gallottini de Magalhães, Suzana Orsini Machado de Sousa.   

Abstract

UNLABELLED: Some oral cancers are known to develop from dysplastic oral epithelium. In the present study, the expression of c-Jun, c-Fos, and cyclin D1 proteins in oral epithelial lesions with different degrees of dysplasia, and in oral squamous cell carcinomas (OSCCs) was evaluated. Eighteen cases of mild dysplasia, 23 cases of moderate to severe dysplasia and 24 OSCCs were studied immunohistochemically. Additionally, 15 sections of oral mucosa without any evidence of dysplasia were included in the study.
RESULTS: c-Jun expression increased according to the degree of oral dysplasia, with the greatest expression found in OSCC. c-Fos expression was intense in normal mucosa, reduced in mild dysplasia and high in moderate to severe dysplasia and in OSCCs. Cyclin D1 was expressed in only a few cases of moderate to severe dysplasia and in most of the OSCCs. Statistical analysis showed a correlation between the three proteins and the degree of epithelial alteration. The present results indicate a possible role of c-Jun and c-Fos in malignant transformation of oral mucosa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050486     DOI: 10.2334/josnusd.47.71

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  17 in total

Review 1.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

2.  Cyclin d1 gene expression in oral mucosa of tobacco chewers"-an immunohistochemical study.

Authors:  Maharudrappa Basnaker; Srikala Sp; Satish Bnvs
Journal:  J Clin Diagn Res       Date:  2014-05-15

3.  Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer.

Authors:  M Rita I Young
Journal:  J Immunother       Date:  2008 Feb-Mar       Impact factor: 4.456

Review 4.  Advances in monoclonal antibody application in myocarditis.

Authors:  Li-na Han; Shuang He; Yu-tang Wang; Li-ming Yang; Si-yu Liu; Ting Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

5.  1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.

Authors:  Kumaran Sundaram; Yuvaraj Sambandam; Eichi Tsuruga; Carol L Wagner; Sakamuri V Reddy
Journal:  Horm Cancer       Date:  2014-02-05       Impact factor: 3.869

6.  Expression of caspase 14 and filaggrin in oral squamous carcinoma.

Authors:  Constance Scharenberg; André Eckardt; Christina Tiede; Hans Kreipe; Kais Hussein
Journal:  Head Neck Pathol       Date:  2013-05-04

7.  Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma.

Authors:  Swati Saawarn; Madhusudan Astekar; Nisheeth Saawarn; Nidhi Dhakar; Shitalkumar Gomateshwar Sagari
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 8.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

9.  The expression and significance of proto-oncogene c-fos in viral myocarditis.

Authors:  Song Zhang; Ben He; Steven Goldstein; Junbo Ge; Zuyue Wang; George Ruiz
Journal:  Virol J       Date:  2010-10-27       Impact factor: 4.099

10.  HPV16E6-dependent c-fos expression contributes to AP-1 complex formation in SiHa cells.

Authors:  Feixin Liang; Shinichiro Kina; Hiroyuki Takemoto; Akira Matayoshi; Thongsavanh Phonaphonh; Nao Sunagawa; Keiichi Arakaki; Akira Arasaki; Hai Kuang; Hajime Sunakawa
Journal:  Mediators Inflamm       Date:  2011-07-31       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.